New drugs, targeted treatments for idiopathic pulmonary fibrosis
Mary Beth Nierengarten is a writer, editor and journalist with over 25 years of medical communications experience. She is a regular contributor to a number of online and print publications and writes in most clinical areas, as well as on health policy and economic issues. She lives in Minneapolis and can be reached at [email protected].
Articles by Mary Beth Nierengarten
2014 ACR/ARHP Annual Meeting: Telomeres and the Aging Immune System
How research into telomere shortening is uncovering links to immune response, inflammatory conditions
2014 ACR/ARHP Annual Meeting: Predicting Outcomes for Patients with Lupus Nephritis
Better understanding of kidney inflammation and fibrosis in LN, along with finding novel disease biomarkers could help rheumatologists gauge patients’ response to therapy
How to Launch a Rheumatology Fellowship Program
Tips on getting started, overcoming challenges, maintaining a successful fellowship program
Pediatric Chronic Pain Eased by Early Intervention, Parental Involvement
Comfort Ability program provides psychological strategies to help children self-manage symptoms
Mortality Rates Improve for Patients with Rheumatoid Arthritis
Emerging research suggests patients with RA are living longer, bolsters support for early aggressive treatment of RA
Kidney Problems More Prevalent in Patients with Rheumatoid Arthritis
Rheumatologists urged to monitor signs of kidney dysfunction in patients with RA as higher incidence of reduced kidney function found in these patients
Knee Replacement Offers Cardiovascular Benefits for Patients with Arthritis
Knee arthroplasty may help prevent cardiovascular disease in patients with osteoarthritis; same-day bilateral surgery safe for select patients with rheumatoid arthritis
Research Into Causes of Systemic Vasculitis May Lead to Targeted Treatments Say Rheumatologists at the 2013 ACR/ARHP Annual Meeting
Studies focused on role of the immune system in disease development, and contributing genetic and environmental factors, may elicit better therapeutic approaches to small- and large-vessel vasculitis
Switches That Regulate Gene Expression Offer Better Understanding of Rheumatic Disease Say Experts at the 2013 ACR/ARHP Annual Meeting
New studies examine why turning on or off switches in genes that control the genome can contribute to pathogenesis of such autoimmune diseases as systemic lupus erythematosus or rheumatoid arthritis